(Sharecast News) - GlaxoSmithKline said its treatment for Covid-19 was effective in treating all tested variants of the virus including key mutations of the Omicron strain.
The FTSE 100 drugs company said it had tested Sotrovimab on specific individual mutations found in Omicron and that the treatment had shown activity against...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE